Creative Planning
SCMP

Creative Planning’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Creative Planning’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,003
Closed -$21K – 4477
2017
Q2 		$21K Buy
2,003
+400
+25% +$4.08K ﹤0.01% 3169
2017
Q1 		$18K Hold
1,603
– – ﹤0.01% 3205
2016
Q4 		$22K Sell
1,603
-1,397
-47% -$19.5K ﹤0.01% 3032
2016
Q3 		$37K Buy
3,000
+2,000
+200% +$23.6K ﹤0.01% 2607
2016
Q2 		$11K Buy
+1,000
New +$11.2K ﹤0.01% 3223
2016
Q1 		– Sell
-2,210
Closed -$38K – 4693
2015
Q4 		$38K Sell
2,210
-1,040
-32% -$18.6K ﹤0.01% 2350
2015
Q3 		$65K Buy
+3,250
New +$74.5K ﹤0.01% 1864

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Creative Planning's SCMP Position: Q3 2017 in Review

Creative Planning sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 2,003 shares — an estimated $21K sold.

Creative Planning first reported a position in SCMP in Q3 2015 and held it in 7 quarters. The position peaked at $65K in Q3 2015. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • Creative Planning reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 2,003 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $21K.
  • Creative Planning first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 7 quarters.
  • Creative Planning's Sucampo Pharmaceuticals, Inc. position peaked at $65K in Q3 2015.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.